 |
|
|
| |
The impact of the COVID-2019 pandemic on HCV testing and treatment in the United States
|
| |
| |
AASLD 2021 Nov 12-15
Martin Hoenigl1,3, Daniela Abramovitz1, Ricardo Flores1, Natasha K Martin1,3*, Nancy Reau4*
1Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, California, USA., 2 Division of Infectious Diseases, Medical University of Graz, Austria 3Population Health Sciences, University of Bristol, UK 4Rush Medical Center, Chicago, IL; *Joint senior author
|
| |
|
|
|
|
|
